Arrowhead Announces IND Filing To Begin Two Trials For Hepatitis B
December 16, 2014 at 14:48 PM EST
(ARWR) jumped 10% today, after the news that the company has filed an IND to the FDA to begin testing two phase 2b trials using its drug ARC-520 in patients with the Hepatitis B virus.
